Case Study: Leading Oncology Company speeds up drug screening with Elucidata’s Drug OmixAtlas

Leading Oncology Company Uses Elucidata’s Drug OmixAtlas to Drive Drug Discovery

Leading Oncology Company, a precision oncology company focused on developing next-generation cancer therapies, was struggling with a manual, error-prone workflow for high-throughput drug screening data. Their cell-viability assay data and related metadata were scattered across Excel files on desktops and cloud drives, making historical data hard to find, standardize, and compare across experiments and teams.

Elucidata implemented its Drug OmixAtlas platform with automated ETL pipelines, data curation, standardization, and harmonization to ingest and organize the screening data. The result was a highly scalable workflow that reduced time to process and store data by about 25x, ingested all historical data in three months, and enabled faster querying, reporting, and cross-experiment comparisons while making the data FAIR.